| Literature DB >> 28751561 |
Laurent Jallades1,2, Lucile Baseggio1,2, Pierre Sujobert1,2,3, Sarah Huet1,2,3, Kaddour Chabane1,2, Evelyne Callet-Bauchu1,2,3, Aurélie Verney2,3, Sandrine Hayette1,2, Jean-Pierre Desvignes4,5, David Salgado4,5, Nicolas Levy4,5,6, Christophe Béroud4,5,6, Pascale Felman1,2, Françoise Berger2,3,7, Jean-Pierre Magaud1,2,3, Laurent Genestier2, Gilles Salles8,3,9, Alexandra Traverse-Glehen2,3,7.
Abstract
Splenic diffuse red pulp lymphoma is an indolent small B-cell lymphoma recognized as a provisional entity in the World Health Organization 2008 classification. Its precise relationship to other related splenic B-cell lymphomas with frequent leukemic involvement or other lymphoproliferative disorders remains undetermined. We performed whole-exome sequencing to explore the genetic landscape of ten cases of splenic diffuse red pulp lymphoma using paired tumor and normal samples. A selection of 109 somatic mutations was then evaluated in a cohort including 42 samples of splenic diffuse red pulp lymphoma and compared to those identified in 46 samples of splenic marginal zone lymphoma and eight samples of hairy-cell leukemia. Recurrent mutations or losses in BCOR (the gene encoding the BCL6 corepressor) - frameshift (n=3), nonsense (n=2), splicing site (n=1), and copy number loss (n=4) - were identified in 10/42 samples of splenic diffuse red pulp lymphoma (24%), whereas only one frameshift mutation was identified in 46 cases of splenic marginal zone lymphoma (2%). Inversely, KLF2, TNFAIP3 and MYD88, common mutations in splenic marginal zone lymphoma, were rare (one KLF2 mutant in 42 samples; 2%) or absent (TNFAIP3 and MYD88) in splenic diffuse red pulp lymphoma. These findings define an original genetic profile of splenic diffuse red pulp lymphoma and suggest that the mechanisms of pathogenesis of this lymphoma are distinct from those of splenic marginal zone lymphoma and hairy-cell leukemia. CopyrightEntities:
Mesh:
Substances:
Year: 2017 PMID: 28751561 PMCID: PMC5622860 DOI: 10.3324/haematol.2016.160192
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941